Q8F3P1 AF NFT

Vitamin B12-dependent ribonucleotide reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiabdyifcsqr7gf7qgarrzncgdhumficpzhxr5hstt3oxo3e2wh4rm/metadata.json
IPFS of structure file: 
bafybeidc7seukwyvqrtxelps7viorupqhsd4kl66wz2lnnrpft5jk7euc4/AF-Q8F3P1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x4F1A72A98D7421CCeD105210D1757162C6CD2081
First NFT owner address (bech32): 
genesis1fud892vdwssuemgs2ggdzat3vtrv6gyp5ps5eq
Current NFT ID #269362 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
269362
Accession (UniProt):
Q8F3P1
Name::
Vitamin B12-dependent ribonucleotide reductase
Experimental Method:
Predicted structure
Sequence source:
Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8F3P1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8F3P1|NRDJ_LEPIN Vitamin B12-dependent ribonucleotide reductase OS=Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) OX=189518 GN=nrdJ PE=3 SV=2 MKMNRHFTVPQNGESSTIQWTKRNSKITNPDGSKVFEANDILVPEDWSQVAVDILAQKYFRRKGVPKYLKKVQEDGIPEWLQKSIPDTEKLESLKPEDRFGGETSALEVFHRLAGCWTYWGYKYKYFSDEESAKIFYDEIVYMLATQMAAPNSPQWFNTGLNWAYGIDGKSQGHYYVDPSTGKLVKSTSAYEHPQPHACFIQSVDDDLVNEGGIMDLWVREARLFKYGSGTGTNFSNLRGENEPLSGGGKSSGLMSFLKIGDRAAGAIKSGGTTRRAAKMVCLDVDHPDIENFIDWKVTEEKKVASLVTGSMLNNRHLNAIMSACYEMEGEDRFNPKKNSSLKKTIQDAKKVLIPDNYIKRVIDLARQGYKEILFEELTTDWQSDAYNTVSGQNSNNSIRLTNEFMAAVEQDQPWNLYFRTEKEKAKVEGRKAKPSQTLRARELWEKISYAAWASADPGTQYHTTINEWHTCPEDGPINASNPCSEYMFLDNTACNLASANLQKFVNLETLNFDVEGFRYLCKLWTIILEISVTMAQFPSKEIAELSYKFRTLGLGYANLGSVLMVLGIPYDSQQAMAITGAISSIMHMTAYATSAEMAKEQGPFVGYAKNQKHMLRVIRNHRRAAYNAPSGDYEGLTITPIGINPAFCPSYMLKAAQEDADLALSLGEKYGFRNAQVTVIAPTGTIGLVMDCDTTGIEPDFTLVKFKKLAGGGYFKIINQSVPYGLKKLGYSPSEIEAIVNYCKGHATLNGAPVINTQALKEKGFTNEILEKVEASLPLAFDINFAFNKFNLGENFLTKNLGISKEIFDSPGFSLLEHLGFTKEDINKANDYVCGTMTIENAPFLKEKDYPVFDCANKCGKYGKRFLSYESHIRIMAAAQPFISGAISKTINLPEEAVIEDIKNAYFLSWKMMIKANALYRDGSKLSQPLNSVLELLNGIEIDDQEEIREATISKDPVQIAEKIVTKYISHRRKLPSRRAGYTQKAIVGGHKVYLRTGEYEDGQIGEIFIDMHKEGAAFRSLMNAFAISVSLGLQHGVPLEEYVDAFTFFKFEPNGIVSGNKHIKMSTSVIDYIFRELAITYLGRYDLGQVAPEDLRGDEIGSKRATAESNGQEKETLSSMTAVIEPTPKKEVETISYSQMISKEKPSSSPSGISLLEEVKLAKIKGYTGDSCSECGSFEMVRNGSCLKCMSCGSTTGCS